Weight Loss and Rising Testosterone: What a Meta-Analysis of Obese Men Shows

Weight Loss and Rising Testosterone: What a Meta-Analysis of Obese Men Shows

October 31, 2026•5 min read

Losing weight raised testosterone - and the more weight men lost, the bigger the rise.

This article walks through the Eur J Endocrinol (2013) paper in plain English: what was studied, what changed, what the limits are, and what it does not prove. Full citation and DOI link are at the end, with a PubMed record.

What the study found

This 2013 meta-analysis in the European Journal of Endocrinology pooled 24 studies of obese men who lost weight through a low-calorie diet or bariatric surgery, looking at changes in sex hormones before and after.

Total testosterone rose by 2.87 nmol/L with a low-calorie diet and by 8.73 nmol/L after bariatric surgery, and the amount of weight lost was the strongest predictor of the rise. Estradiol fell and LH and FSH rose. Most studies were uncontrolled, so the size of the effect is uncertain.

Key finding (from the study record): Total T rose 2.87 nmol/L with low-calorie diet and 8.73 nmol/L with bariatric surgery; amount of weight lost was the best predictor.

How the study was done

  • Design: Systematic review and meta-analysis of 24 studies
  • Who was studied: Obese men (diet or bariatric surgery)
  • Journal / year: Eur J Endocrinol (2013)
  • First author: Corona G et al.

From the abstract: OBJECTIVE: Few randomized clinical studies have evaluated the impact of diet and physical activity on testosterone levels in obese men with conflicting results. Conversely, studies on bariatric surgery in men generally have shown an increase in testosterone levels. The aim of this study is to perform a systematic review and meta-analysis of available trials on the effect of body weight loss on sex hormones levels.

What it means — and what it does not

Useful takeaway: Losing weight raised testosterone - and the more weight men lost, the bigger the rise.

Limits and caveats: Mostly uncontrolled studies; surgery data dominate the large effect.

This evidence can inform a conversation with a licensed provider. It is not a guarantee of similar results for you, and it is not a recommendation to start, stop, or change any medication on your own.

Related research we cite

How this connects to care

AZTRT serves men in Arizona with telehealth evaluation, labs, and provider-guided plans when appropriate. Plans start at $149/month or $357/quarter and include initial labs only. Medication ships three months at a time when prescribed.

Relevant pages on this site:

FAQ

What did this study actually find?

Losing weight raised testosterone - and the more weight men lost, the bigger the rise. The design was: Systematic review and meta-analysis of 24 studies. Population: Obese men (diet or bariatric surgery).

Does this mean I should start treatment?

No. Research informs care; it does not prescribe it. A licensed provider reviews your symptoms, labs, and history before any decision. Results vary.

What are the main limits of this evidence?

Mostly uncontrolled studies; surgery data dominate the large effect.

Keep reading

Reference

Corona G et al. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur J Endocrinol. 2013. https://doi.org/10.1530/EJE-12-0955 · PubMed 23482592.

Next step

Book a free consult with an Arizona-licensed provider. Bring your questions — including anything this study raised for you.

Plans start at $149/month or $357/quarter and include initial labs only. Medication ships three months at a time when prescribed.

Talk to a licensed provider. Results vary. Not medical advice.

Free consult
Book a free consult with an Arizona-licensed provider
Book free consult →

Talk to a licensed provider. Results vary. Not medical advice.

Back to Blog

AZTRT LLC is a management services organization (MSO). AZTRT LLC does not practice medicine, does not provide medical advice, and does not make any medical decisions. All consultations, diagnoses, prescriptions, and treatment decisions are made solely by independent, licensed healthcare providers who are solely responsible for the care they deliver; AZTRT LLC does not own the medical practice and does not control or interfere with the exercise of professional medical judgment. AZTRT LLC provides administrative, business, and technology support services and connects patients with these independent providers and partner pharmacies. AZTRT LLC is not liable for the acts or omissions of any provider or pharmacy. Telemedicine services are available exclusively to residents of Arizona and only when clinically appropriate following a provider consultation and lab review. Prescription products require a valid prescription from a licensed provider. Individual results vary. Statements on this page have not been evaluated by the FDA and are not intended to diagnose, treat, cure or prevent any disease, and are not a substitute for professional medical advice.